Dr Steven Gourlay | Ticker News | Cognitive impairment: A drug for the treatment of Alzheimer's

Dr Steven Gourlay | Ticker News | Cognitive impairment: A drug for the treatment of Alzheimer'sПодробнее

Dr Steven Gourlay | Ticker Insight | Biotech Breakthrough: A clinical step for new Alzheimer’s trialПодробнее

A Quest to Treat Alzheimer’s DiseaseПодробнее

Actinogen Medical - executive interviewПодробнее

The Acceleration of Frontal Temporal Lobe Dementia Symptoms with Amanda SullivanПодробнее

How to Treat Mild Cognitive ImpairmentПодробнее

Actinogen webcast positive Alzheimer’s Disease clinical resultsПодробнее

Alzheimer’s Clinical Trials 2024: The Inside Story with Dr. Jeffrey CummingsПодробнее

Actinogen Medical – executive interviewПодробнее

"What medications can I take to prevent or treat Alzheimer's?" with Dr. Steven TamПодробнее

Actinogen Medical (ASX:ACW) - Webinar PresentationПодробнее

Ep 143 Part 2 - "Reversing Alzheimer’s" Dr. Heather SandisonПодробнее

Special Exercises for Frailty, Alzheimer's & DementiaПодробнее

#Dementia vs #alzheimers, read more via @BeingPatientAlzheimersПодробнее

New treatment could slow cognitive decline of Alzheimer’s Disease | 9 News AustraliaПодробнее

ACW Clinical Trials Science Forum 2023: Alzheimer’s: amyloid therapies are only part of the answerПодробнее

Breakthrough in Alzheimer's Disease ResearchПодробнее

Alzheimer's drug lecanemab can slow cognitive decline, study showsПодробнее